Sign Up to like & get
recommendations!
1
Published in 2020 at "Pediatric diabetes"
DOI: 10.1111/pedi.13062
Abstract: BACKGROUND The TODAY study, a randomized clinical trial of three treatments for type 2 diabetes (T2DM) in youth, demonstrated treatment failure (defined as sustained HbA1c ≥8%, or inability to wean insulin after 3 months after acute…
read more here.
Keywords:
hba1c hypertension;
adhesion molecules;
treatment;
adhesion ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Diabetes"
DOI: 10.2337/db18-154-lb
Abstract: Objective: Determine if SMBG increased after starting insulin in T2D youth with poor glycemic control in the TODAY study. Methods: Youth with recent onset T2D (n=699) were randomized to receive metformin ± rosiglitazone (rosi) or…
read more here.
Keywords:
insulin;
smbg;
a1c;
youth ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Diabetes Care"
DOI: 10.2337/dc18-1935
Abstract: OBJECTIVE In the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study, metformin plus rosiglitazone (M + R) maintained glycemic control better than metformin alone (M) or metformin plus lifestyle (M +…
read more here.
Keywords:
treatment;
type diabetes;
youth;
today study ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Diabetes care"
DOI: 10.2337/dc21-1072
Abstract: OBJECTIVE The Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study reported a 13.9% prevalence of diabetic retinopathy (DR) in youth with mean ± SD type 2 diabetes duration of 4.9 ±…
read more here.
Keywords:
type diabetes;
progression;
diabetic retinopathy;
today study ... See more keywords